BLU - BELLUS Health to launch its $175M stock offering in U.S. and Canada

BELLUS Health (NASDAQ:BLU) trades 2.2% down after hours on filing a prelim prospectus supplement for a proposed public offering of its shares worth $175M; underwriters to be granted 30-day option to purchase up to an additional 15% of the shares. The supplement was filed with each of the securities regulatory authorities in the provinces of Canada and were also filed with the U.S. SEC as part of a registration statement on Form F-­?10. Net proceeds to be used for funding R&D activities, general and administrative expenses, working capital needs and other general corporate purposes. Offer size, terms have not been disclosed yet.

For further details see:

BELLUS Health to launch its $175M stock offering in U.S. and Canada